Rossari Biotech Limited - Company Profile

Q: Who are the current directors of Rossari Biotech Limited?

The current directors of Rossari Biotech Limited are Esha Padmanabhan Achan, Ketan Sablok, Sunil Srinivasan Chari, Aseem Dhru, Gurudas Vishwas Aras, Edward Walter Menezes, Parul Gupta, Aparna Narendra Sharma.

It is a chemicals and materials public limited company based in Mumbai, Maharashtra, India, established in 2009.

2009 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Rossari Biotech Limited

Rossari Biotech Limited, a active public limited company, was established on 10 August 2009 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L24100MH2009PLC194818. Registered under ROC Roc Mumbai. it is listed on BSE: 543213 and NSE: ROSSARI. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹11.08 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹978.77 Cr and a net worth of ₹858.70 Cr. Employing 459 professional, Its leadership includes Esha Padmanabhan Achan (Director), Ketan Sablok (Cfo), Sunil Srinivasan Chari (Managing Director). Past directors included Esha Padmanabhan Achan, Manasi Mohan Nisal, Sharabh Pachory. It holds ₹275.22 Cr open charges and ₹110.54 Cr settled loans. Its latest AGM occurred on 30 June 2025, with the balance sheet filed on 31 March 2025. It is based at Rossari House, Golden Oak, Lbs Marg, Surya Nagar,, Opp. Mahindra Showroom, Vikhroli (West),, Mumbai, Maharashtra, 400079.

Company Details

CIN/LLPIN
L24100MH2009PLC194818
Registration Number
194818
Incorporation Date
10 August 2009
Authorized Capital
₹12.00 Cr
Paid-Up Capital
₹11.08 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 543213, NSE: ROSSARI)
Company Status
Active

Key Metrics

Authorised Capital ₹ 12.00 Cr as on 23-12-2025
Paid Up Capital ₹ 11.08 Cr as on 23-12-2025
Company Age 16 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 275.22 Cr as on 23-12-2025
Satisfied Charges ₹ 110.54 Cr as on 23-12-2025
Revenue Growth **** -9.84% (FY 2023)
Profit Growth **** -10.17% (FY 2023)
Ebitda **** -0.12% (FY 2023)
Net Worth 9.45% (FY 2023)
Total Assets **** 21.57% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Rossari Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Rossari Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Esha Padmanabhan Achan	Director	21 Oct 2023	Current
Ketan Sablok	Cfo	01 May 2023	Current
Sunil Srinivasan Chari	Managing Director	26 Sep 2019	Current
Aseem Dhru	Director	12 Nov 2019	Current
Gurudas Vishwas Aras	Director	19 Oct 2024	Current
Edward Walter Menezes	Whole-Time Director	10 Aug 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	05 Dec 2023	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Additional Director	19 Nov 2019	Past
Pramod Abcsdd	Director	12 Nov 2019	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Additional Director	30 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rossari Biotech.

Rossari Biotech Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.84% decrease. The company also saw a substantial fall in profitability, with a 10.17% decrease in profit. The company's net worth moved up by a moderate rise of 9.45%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-9.84%

*******

Revenue from Operations

*******

-9.10%

*******

Total Assets

*******

21.57%

*******

Profit or Loss

*******

-10.17%

*******

Net Worth

*******

9.45%

*******

EBITDA

*******

-0.12%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rossari Biotech?

In 2023, Rossari Biotech had a promoter holding of 58.40% and a public holding of 41.60%. The company had 5 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,752,150,000.00

Satisfied Charges

₹1,105,439,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 81.62 Cr
Axis Bank Limited : 75.00 Cr
Citi Bank N.A. : 50.00 Cr
The Hongkong And Shanghai Banking Corporation Limited : 30.00 Cr
Standard Chartered Bank : 25.00 Cr
Others : 13.60 Cr

Latest Charge Details

Date	Lender	Amount	Status
06 Nov 2025	Others	₹8.95 M	Open
17 Oct 2025	Others	₹1.20 Cr	Open
23 Feb 2023	Standard Chartered Bank	₹25.00 Cr	Open
12 Oct 2022	Citi Bank N.A.	₹50.00 Cr	Open
15 Oct 2019	Axis Bank Limited	₹75.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Rossari Biotech?

Rossari Biotech has a workforce of 459 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rossari Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossari Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rossari Biotech

Recent Activity within the Organization

Charges

The activity A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101190280 was registered on 06 Nov 2025. was completed.
06 Nov 2025
Charges

A charge with Others amounted to Rs. 1.20 Cr with Charge ID 101181094 was registered on 17 Oct 2025. was recorded as a recent event.
17 Oct 2025
Charges

A charge registered on 12 Oct 2022 via Charge ID 100623997 with Citi Bank N.A. was fully satisfied on 15 Oct 2025. was recorded as a recent event.
15 Oct 2025
Annual General Meeting

Progress on Rossari Biotech Limited last Annual general meeting of members was held on 30 Jun 2025 as per latest MCA records. was documented.
30 Jun 2025
Balance Sheet

Rossari Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Gurudas Vishwas Aras was appointed as a Director was appointed as a Director on 19 Oct 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
19 Oct 2024

Explore recent activity and updates - View Recent Activity